Suchergebnisse - "Aparna, A"

PubPharm (10)

1

Phase 1-2 study of docetaxel plus aflibercept in patients with recurrent ovarian, primary peritoneal, or fallopian tube cancer

enthalten in: The Lancet. Oncology | 2011

von Coleman, R. | Duska, L. | Ramirez, P. | +12

CommentIn: Lancet Oncol. 2011 Nov;12(12):1082-3. - PMID 21992854

2

Clinical and biological impact of EphA2 overexpression and angiogenesis in endometrial cancer

enthalten in: Cancer biology & therapy | 2010

von Merritt, W. | Kamat, A. | Hwang, J. | +16

3

Bridging the gap between cytotoxic and biologic therapy with metronomic topotecan and pazopanib in ovarian cancer

enthalten in: Molecular cancer therapeutics | 2010

von Merritt, W. | Nick, A. | Carroll, A. | +13

4

Frequent downregulation of miR-34 family in human ovarian cancers

enthalten in: Clinical cancer research : an official journal of the American Association for Cancer Research | 2010

von Corney, D. | Hwang, C. | Matoso, A. | +8

5

EphA2 overexpression is associated with lack of hormone receptor expression and poor outcome in endometrial cancer

enthalten in: Cancer | 2009

von Kamat, A. | Coffey, D. | Merritt, W. | +7

6

Functional significance of VEGFR-2 on ovarian cancer cells

enthalten in: International journal of cancer | 2009

von Spannuth, W. | Nick, A. | Jennings, N. | +12

7

Dual targeting of endothelial cells and pericytes in antivascular therapy for ovarian carcinoma

enthalten in: Clinical cancer research : an official journal of the American Association for Cancer Research | 2007

von Lu, C. | Kamat, A. | Lin, Y. | +11

8

EphA2 overexpression is associated with angiogenesis in ovarian cancer

enthalten in: Cancer | 2007

von Lin, Y. | Han, L. | Kamat, A. | +7

9

Efficacy and antivascular effects of EphA2 reduction with an agonistic antibody in ovarian cancer

enthalten in: Journal of the National Cancer Institute | 2006

von Landen, C. | Lu, C. | Han, L. | +16

10

Analysis of EphA2 expression and mutant p53 in ovarian carcinoma

enthalten in: Cancer biology & therapy | 2006

von Merritt, W. | Thaker, P. | Landen, C. | +9

CommentIn: Cancer Biol Ther. 2007 Feb;6(2):288-9. - PMID 17426437

1
[1]